Biotechnology
Healthcare
Medical
GlaxoSmithKline
$40.189876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.19 (0.48%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!
About
GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Employees
95,490
Headquarters
Brentford, Greater London
Founded
1999
Market Cap
99.37B
Price-Earnings Ratio
19.42
Dividend Yield
5.40
Average Volume
2.79M
High Today
$40.32
Low Today
$40.08
Open Price
$40.16
Volume
494.49K
52 Week High
$42.36
52 Week Low
$36.41
Collections
Biotechnology
Healthcare
Medical
Pharmaceutical
Female CEOs
Health
Research And Development
Health And Wellness
News
ReutersMay 24
UK Stocks-Factors to watch on May 24
May 24 (Reuters) - Britain's FTSE 100 index is seen opening 14 points higher at 7,245 on Friday, according to financial bookmakers.
Yahoo FinanceMay 23
GSK to change incentives for sales representatives
(Reuters) - British drugmaker GlaxoSmithKline said on Thursday it will change incentives for sales representatives in some countries as it looks to retain talent.
Seeking AlphaMay 22
Glaxo's Shingrix conditionally OK'd in China
FiercePharma reports that China's National Medical Products Administration has conditionally approved GlaxoSmithKline's (GSK +1.1% ) shingles vaccine Shingrix, allowing it to file for approval there based on data generated in other countries.
Price Paid on Robinhood
4% Higher
Right Now
52 Week Low
$36.41
Average Price Paid
$38.75
52 Week High
$42.36
Earnings
$0.34
$0.52
$0.70
$0.88
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 24